HopeStage
Back to all studies
CompletedNCT00181987

Concerta for ADHD symptoms in children and adults with bipolarity

About this title

Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

Read the official source — NCT00181987
Medication studyAges 6–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 55 years.

Listed locations
CambridgeSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2002
Recruitment status
Completed
Enrollment listed in the registry
29
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 6 Years to 55 Years
Official registry ID
NCT00181987
Official title
Show the full official title

Open-Label Study of Concerta in the Treatment of ADHD in Youth and Adults With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including methylphenidate HCl (Concerta).

Who was this study for?

Listed age limits: 6 years to 55 years.

Want to explore more studies?

Explore studies